AMGN vs. CVS: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and CVS, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AMGN dwarfs CVS in market cap, clocking in at 145.90 billion USD—about 1.86 times the 78.57 billion USD of its counterpart.
AMGN at 0.50 and CVS at 0.60 move in sync when it comes to market volatility.
| Symbol | AMGN | CVS |
|---|---|---|
| Company Name | Amgen Inc. | CVS Health Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| CEO | Mr. Robert A. Bradway | Mr. J. David Joyner CEBS |
| Price | 271.34 USD | 62.11 USD |
| Market Cap | 145.90 billion USD | 78.57 billion USD |
| Beta | 0.497 | 0.6 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 17, 1983 | November 20, 1996 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and CVS over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and CVS, please refer to the table below.
| Symbol | AMGN | CVS |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 14.83 |
| Forward PEG Ratio (TTM) | 7.08 | 1.27 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 0.21 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 1.02 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 13.23 |
| EV-to-EBITDA (TTM) | 15.71 | 10.98 |
| EV-to-Sales (TTM) | 5.70 | 0.40 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 25.20 |
Dividend Comparison
Both AMGN at 3.41% and CVS at 4.28% pay dividends, blending income with growth in their strategies. Their yields align closely, indicating similar income-growth balances.
| Symbol | AMGN | CVS |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 4.28% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and CVS, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- CVS’s current ratio of 0.82 dips below 1, leaving short-term liabilities larger than current assets—a scenario that could hinge on cash flow support. On the other hand, AMGN at 1.17 has enough assets to handle its obligations.
- At 0.63, CVS’s quick ratio falls below 0.8, where liquid assets, minus inventory, can’t keep up with short-term bills—possibly riding on cash flow. By contrast, AMGN hits 0.88, covering its bases comfortably.
- AMGN racks up a D/E of 9.24 over 3.0, leaning hard into debt and flirting with higher risk. Meanwhile, CVS clocks in at 1.06, staying on firmer ground.
| Symbol | AMGN | CVS |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 0.82 |
| Quick Ratio (TTM) | 0.88 | 0.63 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 1.06 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.32 |
| Interest Coverage Ratio (TTM) | 3.19 | 3.18 |